Major reforms have been outlined since the Modi government has come to power. Various improvements have been witnessed in important sectors to align the progress of India. A few reforms in the healthcare sector have been
the introduction of common entrance test (NEET), the new health policy that focussed on sourcing of care from the private sector, an increase in the domestic manufacturing of medical equipment that lead to increase in its affordability and availability, launch of digital India campaign under which e-Health was one of the initiatives which has made receiving lab reports and OPD appointments quicker and simpler. To match the standards of international pharma companies, emphasis has been laid on investing more and more in our research and development.
These upgrades have constantly proved to be a sign of promising success. But as growth needs to be continuous, there are certain areas where attention is required. To talk of the same, we are yet to introduce guidelines in the regulatory space, as establishment of unauthorised laboratories has been witnessed lately. There have been inconsistencies in the Clinical Establishment Act as well. Hence, we require certain protocols to be strictly followed to curb the rise of dubious pathologists. This is essentially because our government is yet to set up appropriate governing and regulatory bodies for quality control.
Being a private authorised diagnostics company, we believe enhancement in health is the primary agenda, with private companies introducing the technology and the public sector letting in subsidies.